The WHO IDA (Ivermectin, Diethylcarbamazine, Albendazole) triple-drug regimen is recommended for accelerating lymphatic filariasis elimination through...

Question

The WHO IDA (Ivermectin, Diethylcarbamazine, Albendazole) triple-drug regimen is recommended for accelerating lymphatic filariasis elimination through MDA. In which areas is IDA contraindicated?

Accepted Answer

Areas co-endemic for onchocerciasis or loiasis, because DEC can cause severe adverse reactions (Mazzotti reaction in onchocerciasis, fatal encephalopathy in loiasis with high microfilaraemia)

Answer

Areas endemic for malaria

Answer

Areas with high HIV prevalence

Answer

Areas with soil-transmitted helminth co-infection

Answer

IDA has no contraindications

uk-dtmh MCQ (SBA): IDA Contraindications

The WHO IDA (Ivermectin, Diethylcarbamazine, Albendazole) triple-drug regimen is recommended for accelerating lymphatic filariasis elimination through MDA. In which areas is IDA contraindicated?